FDA Drug Application (090516) for NABUMETONE by MYLAN PHARMS INC

Back to FDA Applications sponsored by MYLAN PHARMS INC

Application Number090516
Product Number001
FormTABLET;ORAL
Dosage500MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameNABUMETONE
Active IngredientNABUMETONE

Active IngredientCount
List of drugs with Active Ingredient NABUMETONE2


Back to FDA Applications sponsored by MYLAN PHARMS INC